Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2007 by Children's Hospital Boston.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Schering-Plough
Progeria Research Foundation
Information provided by:
Children's Hospital Boston
ClinicalTrials.gov Identifier:
NCT00425607
First received: January 22, 2007
Last updated: December 24, 2007
Last verified: December 2007